Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Obinutuzumab
Chlorambucil
Locations
19
United States
Clearview Cancer Institute
Huntsville, Alabama, United States
Highlands Oncology Group
Rogers, Arkansas, United States
University of California San Diego
La Jolla, California, United States
Bay Area Cancer Research Group, LLC
Pleasant Hill, California, United States
Cancer Center of Central Conn.
Southington, Connecticut, United States
Peachtree Hematology & Oncology Consultants, Pc
Atlanta, Georgia, United States
Start Date
August 1, 2013
Primary Completion Date
January 1, 2014
Completion Date
January 1, 2014
Last Updated
April 17, 2017
NCT06846671
NCT07218341
NCT06548152
NCT07030400
NCT07277231
NCT05006716
Lead Sponsor
Genentech, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions